Tower Research Capital (TRC)’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8K Sell
1,319
-3,486
-73% -$77.5K ﹤0.01% 3174
2025
Q4
$124K Buy
4,805
+1,415
+42% +$33.6K ﹤0.01% 1789
2025
Q3
$87.4K Sell
3,390
-1,234
-27% -$30.3K ﹤0.01% 2112
2025
Q2
$111K Buy
4,624
+3,213
+228% +$81K ﹤0.01% 2296
2025
Q1
$35.1K Sell
1,411
-2,243
-61% -$53.7K ﹤0.01% 2495
2024
Q4
$68.8K Sell
3,654
-8,418
-70% -$148K ﹤0.01% 2376
2024
Q3
$182K Buy
12,072
+6,599
+121% +$113K ﹤0.01% 1717
2024
Q2
$157K Buy
5,473
+4,997
+1,050% +$142K ﹤0.01% 2257
2024
Q1
$13.9K Sell
476
-20,037
-98% -$616K ﹤0.01% 3356
2023
Q4
$692K Buy
20,513
+17,810
+659% +$521K 0.01% 1119
2023
Q3
$82.9K Buy
2,703
+2,081
+335% +$75K ﹤0.01% 2118
2023
Q2
$24.9K Sell
622
-531
-46% -$22K ﹤0.01% 3189
2023
Q1
$47K Sell
1,153
-825
-42% -$32.8K ﹤0.01% 2553
2022
Q4
$76K Sell
1,978
-1,649
-45% -$80.2K ﹤0.01% 2040
2022
Q3
$193K Sell
3,627
-8,096
-69% -$450K ﹤0.01% 1971
2022
Q2
$683K Buy
11,723
+3,670
+46% +$240K 0.02% 936
2022
Q1
$615K Sell
8,053
-5,613
-41% -$374K 0.01% 1032
2021
Q4
$822K Buy
13,666
+12,843
+1,561% +$708K 0.01% 804
2021
Q3
$46K Sell
823
-6,222
-88% -$359K ﹤0.01% 3034
2021
Q2
$427K Buy
7,045
+4,103
+139% +$260K 0.01% 1317
2021
Q1
$206K Sell
2,942
-1,130
-28% -$80.7K ﹤0.01% 1985
2020
Q4
$243K Buy
4,072
+3,154
+344% +$185K 0.01% 1565
2020
Q3
$55K Sell
918
-2,954
-76% -$172K ﹤0.01% 3498
2020
Q2
$203K Buy
+3,872
New +$162K 0.01% 1772
2019
Q4
Sell
-2,551
Closed -$97K 4164
2019
Q3
$97K Buy
2,551
+1,115
+78% +$44.5K 0.01% 1370
2019
Q2
$63K Buy
1,436
+1,157
+415% +$49.1K ﹤0.01% 1457
2019
Q1
$11K Buy
+279
New +$10.9K ﹤0.01% 2640
2018
Q2
Sell
-19
Closed -$1K 3954
2018
Q1
$1K Sell
19
-778
-98% -$27.7K ﹤0.01% 3093
2017
Q4
$36K Sell
797
-6,538
-89% -$259K ﹤0.01% 1584
2017
Q3
$276K Buy
7,335
+7,235
+7,235% +$291K 0.02% 530
2017
Q2
$5K Sell
100
-19
-16% -$882 ﹤0.01% 2005
2017
Q1
$5K Sell
119
-109
-48% -$4.71K ﹤0.01% 2214
2016
Q4
$7K Sell
228
-2,085
-90% -$69.6K ﹤0.01% 2863
2016
Q3
$79K Sell
2,313
-3,623
-61% -$142K 0.01% 917
2016
Q2
$200K Buy
5,936
+5,206
+713% +$256K 0.02% 662
2016
Q1
$39K Buy
730
+624
+589% +$36.5K 0.01% 914
2015
Q4
$8K Sell
106
-1,092
-91% -$61.8K ﹤0.01% 2434
2015
Q3
$49K Buy
1,198
+1,172
+4,508% +$71.8K ﹤0.01% 1035
2015
Q2
$2K Buy
+26
New +$2.05K ﹤0.01% 3770
2015
Q1
Sell
-91
Closed -$8K 4799
2014
Q4
$8K Sell
91
-150
-62% -$14.2K ﹤0.01% 2351
2014
Q3
$23K Buy
241
+151
+168% +$14.7K ﹤0.01% 2188
2014
Q2
$8K Buy
+90
New +$6.85K ﹤0.01% 2534
2014
Q1
Sell
-1,682
Closed -$97K 4818
2013
Q4
$97K Buy
1,682
+972
+137% +$51.1K 0.02% 886
2013
Q3
$34K Sell
710
-35
-5% -$1.27K ﹤0.01% 2250
2013
Q2
$22K Buy
+745
New +$21.6K ﹤0.01% 1623

Other funds holding PCRX